Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccineFriday, August 9, 2024Availability, Epidemiological impactRead More
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling studyFriday, August 9, 2024Availability, Epidemiological impactRead More
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countriesFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccinesFriday, August 9, 2024Accessibility, Implementation strategies and feasibilityRead More
TB vaccine market analysisFriday, August 9, 2024Accessibility, Availability, Economic impact/cost-effectivenss, Economic impact/cost-effectivenss, FInancing strategies, FInancing strategiesRead More
Mixed vaccination strategy for the control of tuberculosis: A case study in China.Tuesday, July 16, 2024Available, demand assessedRead More